Si-Bone (SIBN) Profit After Tax Growth (1y) (2018 - 2026)
Si-Bone (SIBN) Profit After Tax Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.04% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 4.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -27.13% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 108.33% |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn | 28.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.10% |
| Dec 31, 2025 | 66.89% |
| Sep 30, 2025 | 30.56% |
| Jun 30, 2025 | 31.18% |
| Mar 31, 2025 | 40.70% |
| Dec 31, 2024 | 55.58% |
| Sep 30, 2024 | 34.39% |
| Jun 30, 2024 | 20.23% |
| Mar 31, 2024 | 1.99% |
| Dec 31, 2023 | 0.91% |
| Sep 30, 2023 | 28.58% |
| Jun 30, 2023 | 39.47% |
| Mar 31, 2023 | 36.10% |
| Dec 31, 2022 | 24.16% |
| Sep 30, 2022 | 11.59% |
| Jun 30, 2022 | -32.42% |
| Mar 31, 2022 | -42.22% |
| Dec 31, 2021 | -61.84% |
| Sep 30, 2021 | -64.41% |
| Jun 30, 2021 | -12.10% |